Synthesis and antibacterial activity of novel[1,2,4]triazolo[3,4-h][1,8]naphthyridine-7-carboxylic acid derivatives

[1]  Yun Tang,et al.  Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent. , 2014, Bioorganic & medicinal chemistry.

[2]  Vikas Kumar,et al.  Investigation of Ugi-4CC derived 1H-tetrazol-5-yl-(aryl) methyl piperazinyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: synthesis, biology and 3D-QSAR analysis. , 2014, European journal of medicinal chemistry.

[3]  T. Tomašič,et al.  Prospects for developing new antibacterials targeting bacterial type IIA topoisomerases. , 2013, Current topics in medicinal chemistry.

[4]  Jianhua Yu,et al.  Synthesis and biological evaluation of novel 1,2,4-triazole containing 1,2,3-thiadiazole derivatives , 2013 .

[5]  M. Karatepe,et al.  Synthesis and biological activities of some novel aminomethyl derivatives of 4-substituted-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones. , 2013, European journal of medicinal chemistry.

[6]  Nidhi Singh,et al.  SAR analysis of new dual targeting fluoroquinolones. Implications of the benzenesulfonyl group. , 2012, Medicinal chemistry (Shariqah (United Arab Emirates)).

[7]  H. Takiff,et al.  Current Prospects for the Fluoroquinolones as First-Line Tuberculosis Therapy , 2011, Antimicrobial Agents and Chemotherapy.

[8]  H. D. Showalter,et al.  Synthesis and antibacterial activity of the C-7 side chain of 3-aminoquinazolinediones. , 2008, Bioorganic & medicinal chemistry letters.

[9]  R. Bethell,et al.  Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors. , 2006, Journal of medicinal chemistry.

[10]  H. Kondo,et al.  Synthesis and antibacterial activity of thiazolopyrazine-incorporated tetracyclic quinolone antibacterials. , 1994, Journal of medicinal chemistry.